TXMD
TherapeuticsMD, Inc.
Customer concentration
— top 3 customers 100% of revenue
3 customers — 100% of revenue (the three months ended March 31, 2026)
“For the three months ended March 31, 2026, 100% of license revenue related to Mayne Pharma, Theramex and Knight.”
Company with tickers: TXMD
CIK
25743
CUSIP
88338N206
Shares Outstanding
11,574,362
Website
https://www.therapeuticsmd.com
13F Activity (30d)
4 filings
3 filers
Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.
Short Volume
| Date | Short Volume | Short Exempt | Total Volume | Short % |
|---|---|---|---|---|
| 2026-05-15 | 4,163 | 400 | 7,355 | 56.6% |
| 2026-05-18 | 925 | 0 | 5,871 | 15.8% |
| 2026-05-19 | 138 | 9 | 4,770 | 2.9% |
| 2026-05-20 | 2,670 | 4 | 5,667 | 47.1% |
| 2026-05-21 | 3,531 | 0 | 9,146 | 38.6% |
| 2026-05-22 | 3,123 | 0 | 8,110 | 38.5% |
| 2026-05-26 | 4,527 | 0 | 15,549 | 29.1% |
| 2026-05-27 | 8,104 | 0 | 15,148 | 53.5% |
| 2026-05-28 | 4,140 | 1 | 19,027 | 21.8% |
| 2026-05-29 | 1,228 | 0 | 7,024 | 17.5% |
| 2026-06-01 | 5,023 | 2 | 9,876 | 50.9% |
| 2026-06-02 | 11,899 | 2,191 | 115,777 | 10.3% |
| 2026-06-03 | 3,313 | 98 | 16,665 | 19.9% |
| 2026-06-04 | 2,361 | 100 | 5,958 | 39.6% |
| 2026-06-05 | 6,695 | 0 | 18,445 | 36.3% |
| 2026-06-08 | 25,045 | 0 | 102,282 | 24.5% |
| 2026-06-09 | 6,772 | 0 | 37,608 | 18.0% |
| 2026-06-10 | 5,901 | 0 | 19,523 | 30.2% |
| 2026-06-11 | 6,392 | 0 | 33,370 | 19.2% |
| 2026-06-12 | 20,856 | 0 | 129,089 | 16.2% |
| 2026-06-15 | 43,809 | 0 | 79,841 | 54.9% |
Showing 1–21 of 21 days